Skip to main content

Prof. Dr. Tanja Schneider

Member

Institute for Pharmaceutical Microbiology

University Clinic Bonn University of Bonn Meckenheimer Allee 168 53115 Bonn

tschneider@uni-bonn.de

+49 228 735688

Website

  • Mode of action studies on novel antibiotics (e.g. teixobactin, plectasin, lipopeptides)
  • Identification of new antibiotic targets and screening• Antibiotic resistance mechanisms
  • Investigations on bacterial cell envelope biosynthesis, particularly peptidoglycan, wall teichoic acid and capsule biosynthesis
  • Regulation of cell envelope biosynthesis and modification• Additional antiinfective strategies – Antivirulence and combination therapy
  • Screening technologies

Recent publications

  • The Dual Mode of Antibacterial Action of the Synthetic Small Molecule DCAP Involves Lipid II Binding.

    Journal of the American Chemical Society

    Authors: Kevin C Ludwig, Jan-Samuel Puls, Cruz L Matos de Opitz, Paolo Innocenti, Jan-Martin Daniel, Jan Bornikoel, Melina Arts, Sebastian Krannich, Jan Straetener, Dominik Brajtenbach, Beate Henrichfreise, Peter Sass, Anna Mueller, Nathaniel I Martin, Heike Brötz-Oesterhelt, Ulrich Kubitscheck, Fabian Grein, Tanja Schneider

    View this publication
  • Biosynthesis of the corallorazines, a widespread class of antibiotic cyclic lipodipeptides.

    RSC chemical biology

    Authors: Teresa M Dreckmann, Lisa Fritz, Christian F Kaiser, Sarah M Bouhired, Daniel A Wirtz, Marvin Rausch, Anna Müller, Tanja Schneider, Gabriele M König, Max Crüsemann

    View this publication
  • Altering glycopeptide antibiotic biosynthesis through mutasynthesis allows incorporation of fluorinated phenylglycine residues.

    RSC chemical biology

    Authors: Irina Voitsekhovskaia, Y T Candace Ho, Christoph Klatt, Anna Müller, Daniel L Machell, Yi Jiun Tan, Maxine Triesman, Mara Bingel, Ralf B Schittenhelm, Julien Tailhades, Andreas Kulik, Martin E Maier, Gottfried Otting, Wolfgang Wohlleben, Tanja Schneider, Max Cryle, Evi Stegmann

    View this publication